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Abstract HslVU is an ATP-dependent protease consisting of
two multimeric components, the HslU ATPase and the HslV
peptidase. To gain an insight into the role of HslVU in regulation
of cell division, the reconstituted enzyme was incubated with
SulA, an inhibitor of cell division in Escherichia coli, or its fusion
protein with maltose binding protein (MBP). HslVU degraded
both proteins upon incubation with ATP but not with its non-
hydrolyzable analog, ATPQS, indicating that the degradation of
SulA requires ATP hydrolysis. The pulse-chase experiment using
an antibody raised against MBP-SulA revealed that the stability
of SulA increased in hsl mutants and further increased in lon/hsl
double mutants, indicating that SulA is an in vivo substrate of
HslVU as well as of protease La (Lon). These results suggest
that HslVU in addition to Lon plays an important role in
regulation of cell division through degradation of SulA.
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1. Introduction
One of the prominent events of protein breakdown in pro-
karyotes as well as in eukaryotic cells is the requirement of
metabolic energy. A number of proteolytic enzymes responsi-
ble for the ATP-dependent process in Escherichia coli has
been identi¢ed [1,2]. Of these, protease La (Lon) is a heat
shock protein and plays an essential role in the hydrolysis
of most abnormal proteins and certain short-lived regulatory
proteins, such as SulA, which is an inhibitor of cell division
[3]. Protease Ti (Clp), unlike Lon, consists of two di¡erent
multimeric components, both of which are required for pro-
teolysis [4,5]. While ClpA contains the ATP-hydrolyzing sites,
ClpP, which is a heat shock protein, contains a serine active
site for proteolysis. ClpP alone can rapidly cleave small pep-
tides, although it absolutely requires ATP hydrolysis by ClpA
for degradation of large polypeptides [6]. ClpA is a member of
a family of highly conserved polypeptides, present in both
prokaryotic and eukaryotic organisms [7]. In fact, the ClpP
peptidase can function together with one of the homologous
ATPases, ClpX, in degradation of certain regulatory proteins,
such as VO protein [8,9] and the bacteriophage Mu vir repress-
or [10].
Like protease Ti, HslVU consists of two distinct multimeric
components: a 19 kDa HslV and a 50 kDa HslU [11,12].
HslV harbors the peptidase activity, whereas HslU provides
an essential ATPase activity, both of which can function to-
gether as a novel two-component protease [12^14]. HslU itself
has ATPase activity, whereas HslV by itself is a weak pepti-
dase that slowly degrades certain hydrophobic peptides, such
as N-carbobenzoxy (Cbz)-Gly-Gly-Leu-7-amide-4-methyl-cou-
marin (AMC), and polypeptides, including insulin B-chain
and casein [13,15]. In the reconstituted enzyme, HslU mark-
edly stimulates the proteolytic activity of HslV (more than 20-
fold), whereas HslV increases the rate of ATP hydrolysis by
HslU several-fold.
All of the soluble ATP-dependent proteases in E. coli have
been shown to exhibit protein-activated ATPase activity.
Therefore, it has been suggested that hydrolysis of ATP and
peptide bond occurs in a tightly coupled process. However, we
have recently demonstrated that HslVU protease does not
require ATP hydrolysis for its proteolytic activity, unlike pro-
teases La and Ti. Non-hydrolyzable ATP analogs, such as
ATPQS and L,Q-imido-ATP, have been shown to be capable
of supporting the ability of HslVU protease in degrading in-
sulin B-chain and the £uorogenic peptide even better than
ATP [16,17]. Moreover, HslU/C287V, which is unable to hy-
drolyze ATP, could also support the HslV-mediated degrada-
tion of the substrates in the presence of ATP, although to a
lesser extent than the wild-type HslU at its low protein con-
centration [18]. Therefore, the precise function of ATP hydrol-
ysis by HslVU protease remains obscure.
The SulA protein of E. coli is encoded by the SOS-inducible
sulA gene, which is also called s¢A. The target for SulA is the
essential cell division protein FtsZ, which is a GTPase and
plays a critical role in the initiation of cell division [19^21].
s¢A mutants were initially isolated based on suppression of
mutation in lon, which encodes protease La [22,23]. Later, it
has been demonstrated that the suppression is due to rapid
degradation of SulA by protease La. The SulA protein has a
high tendency to aggregate in vivo as well as in vitro and
therefore, its puri¢cation has been facilitated by a genetic
manipulation to fuse maltose binding protein (MBP) to
SulA. This fusion protein has also been shown to retain the
inhibitory function in vivo and to behave as a substrate for
protease La in vitro [24].
Recently, Khattar [25] has reported that overexpression of
the hslVU operon, which encodes HslV and HslU, suppresses
SOS-mediated inhibition of cell division. This ¢nding raised a
possibility that HslVU protease can degrade SulA. In the
present studies, therefore, we examined whether the SulA pro-
tein behaves as an in vivo as well as in vitro substrate for
HslVU protease, in an attempt to determine the role of
HslVU protease in regulation of cell division.
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2. Materials and methods
2.1. Bacterial strains and plasmids
The plasmid pGEM/R9 carries lonR9, which has a single point
mutation in the lon gene [26]. An internal portion of lonR9 in
pGEM/R9 (0.8 kb ClaI/NruI fragment) was replaced by a 1.4 kb
ClaI/SmaI fragment containing the tetracycline resistance (tet) gene
of pBR322. The resulting plasmid was treated with an appropriate
restriction enzyme and introduced into a JC7623 strain (recBC, sbcB)
by selecting for tetracycline resistance. One of the transformants car-
rying lon: :tet on the chromosome was transduced into MC1000
(araD139 v(ara-leu)7679 galU galK v(lac)174 rpsL thi-1) by phage
P1 [27] and the resulting mutant was referred to as MC1000L. For
constructing a MC1000H strain carrying hslVU: :kan, pGEM-T/
HslVU [13] was cut with TthIII1, gap-¢lled with Klenow fragment
and ligated with a 1.5 kb SmaI fragment containing the kanamycin
resistance (kan) gene of pUC4 (type KIXX, Pharmacia). The resulting
plasmid was then introduced into JC7623 and one of the transform-
ants was transduced into MC1000 as above. A MC1000LH strain
(lon: :tet, hslVU: :kan) was obtained by P1 transduction of
MC1000H grown in a JC7623 strain carrying lon: :tet.
For in vivo experiments, these cells were transformed with pSulA5
[28], which carries the wild-type sulA gene under control of the
lacUV5 promoter. pMAL-p2-SulA was transformed into MC1000
cells for overproduction of MBP-SulA [29]. pMAL-p2-SulA and
pSulA5 were obtained from Dr A. Higashitani (National Institute
of Genetics, Japan).
2.2. Protein puri¢cation
The puri¢ed HslV and HslU were prepared as described previously
[13]. The HslU mutant proteins, HslU/C287V, HslU/C287A and
HslU/C287S, in which the Cys287 residue was replaced with Val,
Ala and Ser, respectively, were puri¢ed as described [18]. MBP-SulA
was puri¢ed from MC1000 cells carrying pMAL-p2-SulA by a⁄nity
chromatography on amylose resin (New England Biolabs) [24]. The
protein concentration was determined as described by Bradford [30]
using bovine serum albumin as a standard.
2.3. In vitro degradation of MBP-SulA and SulA by HslVU
Incubations were carried out at 37‡C in the reaction mixtures (0.1
ml) containing 0.1 M Tris-HCl (pH 8), 10 mM MgCl2, 1 mM EDTA,
1 mM dithiothreitol, 5 Wg MBP-SulA, 0.5 Wg HslV and 2 Wg HslU in
the absence or presence of various adenine nucleotides. After incuba-
tion, the reaction was stopped by adding 30 Wl of 0.75 M Tris-HCl
(pH 6.8) containing 7.5% SDS and 10% (v/v) 2-mercaptoethanol.
They were then subjected to polyacrylamide gel electrophoresis
(PAGE) on 13% (w/v) slab gels containing SDS and 2-mercaptoetha-
nol [31]. The gels were stained with Coomassie blue R-250.
Since MBP-SulA has a unique cleavage site of factor Xa (FXa)
(New England Biolabs) in the linker region between MBP and
SulA, 5 Wg of the fusion protein was ¢rst incubated with 0.6 Wg of
FXa for 30 min at 25‡C. After incubation, the reaction was stopped
by adding 1,5-dansyl-Glu-Gly-Arg chloromethyl ketone (CALBIO-
CHEM), a speci¢c inhibitor of FXa, to a ¢nal concentration of
2 WM. The SulA protein generated from MBP-SulA was then incu-
bated with puri¢ed HslVU protease at 37‡C for 2 h. The samples were
subjected to SDS-PAGE as above.
2.4. In vivo degradation of SulA
Cells containing pSulA5 were grown at 30‡C in M9 glycerol me-
dium [32] supplemented with all of the amino acids except Met. After
IPTG induction for 10 min, cells were pulse-labelled with [35S]Met
(10 WCi/ml, 1000 Ci/mmol) for 2 min and then chased for various
periods. The resulting samples were immediately subjected to immu-
noprecipitation using an anti-MBP-SulA antibody [33], followed by
SDS-PAGE. The gels were dried and exposed to X-ray ¢lms. The
radioactivity in the band corresponding to SulA was quanti¢ed using
a Phosphorimager (Fuji).
3. Results and discussion
3.1. Degradation of MBP-SulA by puri¢ed HslVU protease
In order to determine whether HslVU protease can degrade
SulA, the enzyme was incubated with puri¢ed MBP-SulA fu-
sion protein for various periods followed by electrophoresis
under denaturing conditions (Fig. 1). The band corresponding
to MBP-SulA (60 kDa) was diminished with a concomitant
appearance of a new band with a size of about 45 kDa
(marked with an arrowhead) upon incubation with ATP.
The 45 kDa fragment is likely to be a degradation product,
composed mainly of MBP (molecular mass about 42 kDa).
Thus, it appears that HslVU protease speci¢cally degrades the
SulA portion of MBP-SulA.
On the other hand, little or no degradation of MBP-SulA
by HslVU was observed when ATP was replaced with ATPQS,
a non-hydrolyzable analog of ATP (Fig. 2A). Even dATP
could not support the degradation of MBP-SulA, despite
our previous ¢nding that dATP is hydrolyzed and supports
the cleavage of a peptide, Cbz-Gly-Gly-Leu-AMC, by HslVU
protease approximately 30% as well as ATP [13]. This abso-
lute requirement of ATP and its hydrolysis for the degrada-
tion of MBP-SulA is not consistent with the recent reports
revealing that non-hydrolyzable ATP analogs can support the
ability of HslVU protease to degrade insulin B-chain, casein
and the peptide substrate and that HslU/C287V, which is un-
able to hydrolyze ATP, could also support the HslV-mediated
degradation of the substrates in the presence of ATP [16^18].
In order to clarify the requirement of ATP hydrolysis fur-
ther, we compared the ability of HslU mutant proteins in
supporting the degradation of MBP-SulA by HslV. As shown
in Fig. 2B, the wild-type HslU, HslU/C287A and HslU/
C287S, but not HslU/C287V, supported the HslV-mediated
degradation of MBP-SulA in the presence of ATP. As already
reported [18], HslU/C287A and HslU/C287S, unlike HslU/
C287V, can hydrolyze ATP and support the HslV-mediated
hydrolysis of insulin B-chain nearly as well as the wild-type
HslU. These results indicate that ATP hydrolysis is essential
for the degradation of MBP-SulA by HslVU protease. Since
insulin B-chain and casein are known to lack any appreciable
secondary structure, it appears to be possible that ATP hy-
drolysis by HslVU protease is required for unfolding of MBP-
SulA for channeling into the central cavity of HslV, where the
active site is located [34]. In fact, protease La has been dem-
Fig. 1. Time course for degradation of MBP-SulA by puri¢ed
HslVU protease. MBP-SulA (5 Wg) was incubated with HslV (0.5
Wg), HslU (2 Wg) and 2 mM ATP for the indicated periods, fol-
lowed by SDS-PAGE as described under Section 2. The numerals
on top of the gel show the time of incubation and the arrowhead
on the right indicates the degradation product from MBP-SulA.
The letter M indicates the lane containing size markers.
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onstrated to degrade the unfolded form of CcdA, but not its
native form, without ATP hydrolysis [35].
3.2. Degradation of SulA by HslVU in vitro and in vivo
To determine whether HslVU can degrade SulA as well as
MBP-SulA, SulA was generated by treating MBP-SulA with
FXa and then incubated with HslVU in the presence of ATP
or its analogs. Fig. 3 shows that HslVU can degrade SulA in
the presence of ATP but not with ATPQS or dATP. On the
other hand, MBP generated from MBP-SulA by FXa re-
mained intact under the same conditions. These results con-
¢rm that ATP hydrolysis is essential for the degradation of
SulA, unlike that of insulin B-chain or the peptide substrate
[16].
In order to determine whether SulA is also degraded in vivo
by HslVU, the wild-type and hsl null mutant cells were pulse-
labelled with [35S]Met, followed by chasing with an excess of
unlabelled Met. Since protease La (Lon) is known to rapidly
degrade SulA [36], lon and lon/hsl mutant cells were also sub-
jected to pulse-chase experiments for comparison. As previ-
ously reported [37], lon mutation markedly increased the half-
life of SulA from 3 to 25 min (Fig. 4). SulA was further
stabilized to a half-life of 65 min in a lon/hsl double mutant,
although it was slightly stabilized by the hsl mutation alone.
These results indicate that SulA behaves as an in vivo sub-
strate of HslVU protease as well as of protease La.
It has recently been reported that overexpression of HslVU
in lon mutant cells blocks SOS-mediated inhibition of cell
division [25]. It has also been shown that constitutive expres-
sion of SulA prevents colony formation of E. coli [38]. In
addition, we found that the cell growth was more severely
arrested when overexpression of SulA was induced in a lon/
hsl mutant than in the cells carrying a lon mutation alone
(data not shown). Thus, it appears that HslVU protease, in
addition to protease La, plays an important role in regulation
of cell division through degradation of SulA.
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